Lemonade shares plunged 6.5% on Friday, marking the largest one-day decline in over two months. Trading volume totaled 227,836 shares through mid-day, representing a 91% drop from the stock’s average daily turnover of approximately 2.4 million shares. The abrupt sell-off erased most of the prior session’s gains and left the company’s market capitalization near 5.6 billion USD, suggesting investor caution about near-term catalysts.

Recent research reports reveal a divided sentiment among Wall Street strategists. Citigroup reaffirmed its outperform view, while Piper Sandler shifted to a neutral stance and lowered its target by roughly 8%. JMP Securities maintains an optimistic outlook with an $80 objective, even as Keefe, Bruyette & Woods upgraded its underperform judgment by raising its own target to 40. MarketBeat’s consensus rating stands at Hold, with the average target sitting around 63, reflecting a nearly 20% downside from current levels if fully realized.

In its latest quarterly earnings, Lemonade delivered revenue of 194.5 million USD, exceeding analyst expectations by over 5 million USD and marking a 42.4% year-over-year increase. Although loss per share narrowed to approximately 0.51 USD—beating consensus by nearly 0.21 USD—the company still reported a negative return on equity of 31.9% and a net margin of –26.4%. Forecasts call for full-year losses of roughly 3.03 USD per share, underscoring the challenge of translating revenue growth into profitability.

Senior executives have been net sellers, with the COO and a board director reducing their combined stake by more than 18% and 16% respectively in recent weeks, generating over 4.6 million USD in proceeds. Meanwhile, large institutions remain believers: Vanguard bumped its holding by nearly 1%, and JPMorgan Chase increased its stake by over 30% during the third quarter. Overall, hedge funds and mutual funds control just over 80% of outstanding shares, indicating entrenched long-term positions despite recent volatility.